Enliven Therapeutics
ELVN
ELVN
34 hedge funds and large institutions have $302M invested in Enliven Therapeutics in 2020 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 7 closing their positions.
Holders
34
Holders Change
+17
Holders Change %
+100%
% of All Funds
0.7%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
24
Increased
4
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$45.7M |
| 2 |
2
BlackRock
New York
|
$9.48M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$5.44M |
| 4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$2.28M |
| 5 |
5
Northern Trust
Chicago,
Illinois
|
$1.77M |
